Khuong Chau Quang

Director at Nabriva Therapeutics Legacy plc · on record since Dec 30, 2016
10% owner at Nabriva Therapeutics Legacy plc · on record since Dec 30, 2016
Director at OTONOMY, INC. · on record since Aug 19, 2014
10% owner at OTONOMY, INC. · on record since Aug 19, 2014
Director at PALVELLA THERAPEUTICS, INC. · on record since Jun 29, 2015
10% owner at PALVELLA THERAPEUTICS, INC. · on record since Jun 29, 2015
Director at Whitehawk Therapeutics, Inc. · on record since Mar 17, 2017
10% owner at Whitehawk Therapeutics, Inc. · on record since Mar 17, 2017
Director at SYNLOGIC, INC. · on record since Aug 30, 2017
Director at NextCure, Inc. · on record since Jun 17, 2019
Director at Fusion Pharmaceuticals Inc. · on record since Jun 30, 2020
Director at Damora Therapeutics, Inc. · on record since Oct 28, 2020
10% owner at Damora Therapeutics, Inc. · on record since Oct 28, 2020
Director at Inspire Medical Systems, Inc. · on record since May 9, 2018
10% owner at Inspire Medical Systems, Inc. · on record since May 9, 2018

Insider trading activity of Khuong Chau Quang

Transactions on record: 128; since Aug 19, 2014

Open-market buys: 11; $47.4M

Open-market sells: 30; $185.2M

Companies traded: 9; last filing Jun 23, 2023

Figures computed from official regulatory filings — .

Companies where Khuong Chau Quang has traded

NextCure, Inc.14 tx · $5.3M · Jun 23, 2023
21 tx · $18.6M · Jun 15, 2023
11 tx · $22.2M · Jun 14, 2023
7 tx · $12M · Apr 22, 2021
38 tx · $178.6M · Oct 13, 2020
4 tx · $6.8M · Jun 19, 2019
14 tx · $1.4M · Oct 27, 2017
3 tx · Jun 27, 2017
16 tx · $14.4M · Jun 21, 2016

Track record of Khuong Chau Quang

Statistical track record

Free account

Open-market buys: 12

Last buy: Nov 2, 2020

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Khuong Chau Quang

Co-insiders of Khuong Chau Quang

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
NextCure, Inc.Listing on record	Jun 23, 2023	AwardD (derivative)	14,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Damora Therapeutics, Inc.Listing unverified	Jun 15, 2023	AwardD (derivative)	18,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Fusion Pharmaceuticals Inc.Listing unverified	Jun 14, 2023	AwardD (derivative)	17,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Fusion Pharmaceuticals Inc.Listing unverified	Nov 14, 2022	Award	42,093	2.38 USD	$100.2K		SEC
NextCure, Inc.Listing on record	Jun 24, 2022	AwardD (derivative)	14,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Fusion Pharmaceuticals Inc.Listing unverified	Jun 22, 2022	AwardD (derivative)	17,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Damora Therapeutics, Inc.Listing unverified	Jun 15, 2022	AwardD (derivative)	18,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Damora Therapeutics, Inc.Listing unverified	Nov 19, 2021	AwardD (derivative)	9,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NextCure, Inc.Listing on record	Jun 28, 2021	AwardD (derivative)	14,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Fusion Pharmaceuticals Inc.Listing unverified	Jun 7, 2021	AwardD (derivative)	17,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Damora Therapeutics, Inc.Listing unverified	May 28, 2021	AwardD (derivative)	18,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SYNLOGIC, INC.Listing on record	Apr 22, 2021	Award	1,666,666	3.00 USD	$5M	Unusual size	SEC
Damora Therapeutics, Inc.Listing unverified	Nov 4, 2020	OtherD (derivative)	-73,773	—	n/a (No price was disclosed in the filing)		SEC
Damora Therapeutics, Inc.Listing unverified	Nov 4, 2020	AwardD (derivative)	-148,395	27.11 USD	$4M	Unusual size	SEC
Damora Therapeutics, Inc.Listing unverified	Nov 4, 2020	OtherD (derivative)	-272,533	—	n/a (No price was disclosed in the filing)		SEC
Damora Therapeutics, Inc.Listing unverified	Nov 4, 2020	Buy	209,500	15.00 USD	$3.1M	conv 33Cluster	SEC
Damora Therapeutics, Inc.Listing unverified	Nov 4, 2020	AwardD (derivative)	-73,773	27.11 USD	$2M	Unusual size	SEC
Damora Therapeutics, Inc.Listing unverified	Nov 4, 2020	OtherD (derivative)	-109,013	—	n/a (No price was disclosed in the filing)		SEC
Damora Therapeutics, Inc.Listing unverified	Nov 4, 2020	Other	822,311	—	n/a (No price was disclosed in the filing)		SEC
Damora Therapeutics, Inc.Listing unverified	Nov 4, 2020	OtherD (derivative)	-148,395	—	n/a (No price was disclosed in the filing)		SEC
Damora Therapeutics, Inc.Listing unverified	Nov 4, 2020	OtherD (derivative)	-116,800	—	n/a (No price was disclosed in the filing)		SEC
Damora Therapeutics, Inc.Listing unverified	Nov 4, 2020	Buy	523,833	15.00 USD	$7.9M	conv 42Cluster	SEC
Damora Therapeutics, Inc.Listing unverified	Nov 4, 2020	OtherD (derivative)	-59,350	—	n/a (No price was disclosed in the filing)		SEC
Damora Therapeutics, Inc.Listing unverified	Nov 4, 2020	Other	2,055,824	—	n/a (No price was disclosed in the filing)		SEC
Damora Therapeutics, Inc.Listing unverified	Nov 4, 2020	OtherD (derivative)	-31,147	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
NextCure, Inc.Listing on record	Jun 23, 2023	AwardD (derivative)	14,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Damora Therapeutics, Inc.Listing unverified	Jun 15, 2023	AwardD (derivative)	18,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Fusion Pharmaceuticals Inc.Listing unverified	Jun 14, 2023	AwardD (derivative)	17,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Fusion Pharmaceuticals Inc.Listing unverified	Nov 14, 2022	Award	42,093	2.38 USD	$100.2K		SEC
NextCure, Inc.Listing on record	Jun 24, 2022	AwardD (derivative)	14,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Fusion Pharmaceuticals Inc.Listing unverified	Jun 22, 2022	AwardD (derivative)	17,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Damora Therapeutics, Inc.Listing unverified	Jun 15, 2022	AwardD (derivative)	18,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Damora Therapeutics, Inc.Listing unverified	Nov 19, 2021	AwardD (derivative)	9,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NextCure, Inc.Listing on record	Jun 28, 2021	AwardD (derivative)	14,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Fusion Pharmaceuticals Inc.Listing unverified	Jun 7, 2021	AwardD (derivative)	17,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Damora Therapeutics, Inc.Listing unverified	May 28, 2021	AwardD (derivative)	18,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SYNLOGIC, INC.Listing on record	Apr 22, 2021	Award	1,666,666	3.00 USD	$5M	Unusual size	SEC
Damora Therapeutics, Inc.Listing unverified	Nov 4, 2020	OtherD (derivative)	-73,773	—	n/a (No price was disclosed in the filing)		SEC
Damora Therapeutics, Inc.Listing unverified	Nov 4, 2020	AwardD (derivative)	-148,395	27.11 USD	$4M	Unusual size	SEC
Damora Therapeutics, Inc.Listing unverified	Nov 4, 2020	OtherD (derivative)	-272,533	—	n/a (No price was disclosed in the filing)		SEC
Damora Therapeutics, Inc.Listing unverified	Nov 4, 2020	Buy	209,500	15.00 USD	$3.1M	conv 33Cluster	SEC
Damora Therapeutics, Inc.Listing unverified	Nov 4, 2020	AwardD (derivative)	-73,773	27.11 USD	$2M	Unusual size	SEC
Damora Therapeutics, Inc.Listing unverified	Nov 4, 2020	OtherD (derivative)	-109,013	—	n/a (No price was disclosed in the filing)		SEC
Damora Therapeutics, Inc.Listing unverified	Nov 4, 2020	Other	822,311	—	n/a (No price was disclosed in the filing)		SEC
Damora Therapeutics, Inc.Listing unverified	Nov 4, 2020	OtherD (derivative)	-148,395	—	n/a (No price was disclosed in the filing)		SEC
Damora Therapeutics, Inc.Listing unverified	Nov 4, 2020	OtherD (derivative)	-116,800	—	n/a (No price was disclosed in the filing)		SEC
Damora Therapeutics, Inc.Listing unverified	Nov 4, 2020	Buy	523,833	15.00 USD	$7.9M	conv 42Cluster	SEC
Damora Therapeutics, Inc.Listing unverified	Nov 4, 2020	OtherD (derivative)	-59,350	—	n/a (No price was disclosed in the filing)		SEC
Damora Therapeutics, Inc.Listing unverified	Nov 4, 2020	Other	2,055,824	—	n/a (No price was disclosed in the filing)		SEC
Damora Therapeutics, Inc.Listing unverified	Nov 4, 2020	OtherD (derivative)	-31,147	—	n/a (No price was disclosed in the filing)		SEC